Degree of Damage to the Small Bowel and Serum Antibody Titers Correlate With Clinical Presentation of Patients With Celiac Disease

Clinical Gastroenterology and Hepatology

Volumn 11, Issue 2, 2013, Pages

  Taavela, Juha ^a   Kurppa, Kalle ^a   Collin, Pekka ^a,b   Lähdeaho, Marja Leena ^a   Salmi, Teea ^a,b   Saavalainen, Päivi ^c   Haimila, Katri ^d   Huhtala, Heini ^a   Laurila, Kaija ^a   Sievänen, Harri ^e   Mäki, Markku ^a   Kaukinen, Katri ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

^e UKK INSTITUTE FOR HEALTH PROMOTION RESEARCH   (Finland)

Author keywords

Antitransglutaminase 2; ; Determinant; Diagnosis; ; Prognosis;

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; IMMUNOGLOBULIN A; IRON;

ADOLESCENT; ADULT; AGE; AGED; ANTIBODY TITER; ANXIETY DISORDER; ARTICLE; BODY MASS; BONE DENSITY; CD3+ T LYMPHOCYTE; CELIAC DISEASE; CONSTIPATION; CORRELATIONAL STUDY; DEPRESSION; DIARRHEA; ERYTHROCYTE; FAMILY HISTORY; FEMALE; FEMUR; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL PAIN; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HEALTH STATUS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; INDIGESTION; INJURY SEVERITY; INTESTINE EPITHELIUM; INTESTINE INJURY; INTESTINE MUCOSA; INTESTINE VILLUS; IRON BLOOD LEVEL; LABORATORY TEST; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; SELF CONTROL; SEROLOGY; STOMACH BIOPSY; VITAMIN BLOOD LEVEL; WELLBEING;

EID: 84872386352     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.09.030     Document Type: Article

References (44)

1. Kaukinen K., Lindfors K., Collin P., et al. Coeliac disease-a diagnostic and therapeutic challenge. Clin Chem Lab Med 2010, 48:1205-1216.
2. Walker-Smith J.A., Guandalini S., Schmitz J., et al. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990, 65:909-911.
3. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ("celiac sprue"). Gastroenterology 1992, 102:330-354.
4. Dorn S.D., Hernandez L., Minaya M.T., et al. Psychosocial factors are more important than disease activity in determining gastrointestinal symptoms and health status in adults at a celiac disease referral center. Dig Dis Sci 2010, 55:3154-3163.
5. Thomas H.J., Ahmad T., Rajaguru C., et al. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand J Gastroenterol 2009, 44:1076-1083.
6. Weizman Z., Ben-Zion Y.Z., Binsztok M., et al. Correlation of clinical characteristics and small bowel histopathology in celiac disease. J Pediatr Gastroenterol Nutr 1997, 24:555-558.
7. Husby S., Koletzko S., Korponay-Szabó I.R., et al. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr 2012, 54:136-160.
8. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
9. Kuitunen P., Kosnai I., Savilahti E. Morphometric study of the jejunal mucosa in various childhood enteropathies with special reference to intraepithelial lymphocytes. J Pediatr Gastroenterol Nutr 1982, 1:525-531.
10. Oberhuber G., Granditsch G., Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999, 11:1185-1194.
11. Järvinen T.T., Kaukinen K., Laurila K., et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003, 98:1332-1337.
12. Dimenäs E., Carlsson G., Glise H., et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996, 221:8-13.
13. Häuser W., Stallmach A., Caspary W.F., et al. Predictors of reduced health-related quality of life in adults with coeliac disease. Aliment Pharmacol Ther 2007, 25:569-578.
14. Hallert C., Grännö C., Grant C., et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol 1998, 33:933-938.
15. Svedlund J., Sjödin I., Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988, 33:129-134.
16. Dupuy H.J. The psychological general well-being (PGWB) index. Assessment of quality of life in clinical trial of cardiovascular therapies 1984, 184-188. Le Jacq Publishing, New York. N.K. Wenger, M.E. Mattson, C.D. Furberg (Eds.).
17. Koskinen L., Romanos J., Kaukinen K., et al. Cost-effective HLA typing with tagging SNPs predicts celiac disease risk haplotypes in the Finnish, Hungarian, and Italian populations. Immunogenetics 2009, 61:247-256.
18. Sievänen H., Kannus P., Nieminen V., et al. Estimation of various mechanical characteristics of human bones using dual energy X-ray absorptiometry: methodology and precision. Bone 1996, 18:17S-27S.
19. Kurppa K., Collin P., Sievänen H., et al. Gastrointestinal symptoms, quality of life and bone mineral density in mild enteropathic coeliac disease: a prospective clinical trial. Scand J Gastroenterol 2010, 45:305-314.
20. Cuomo A., Romano M., Rocco A., et al. Reflux oesophagitis in adult coeliac disease: beneficial effect of a gluten free diet. Gut 2003, 52:514-517.
21. Viljamaa M., Collin P., Huhtala H., et al. Is coeliac disease screening in risk groups justified?. A fourteen-year follow-up with special focus on compliance and quality of life. Aliment Pharmacol Ther 2005, 22:317-324.
22. Ludvigsson J.F., Reutfors J., Osby U., et al. Coeliac disease and risk of mood disorders-a general population-based cohort study. J Affect Disord 2007, 99:117-126.
23. Addolorato G., Capristo E., Ghittoni G., et al. Anxiety but not depression decreases in coeliac patients after one-year gluten-free diet: a longitudinal study. Scand J Gastroenterol 2001, 36:502-506.
24. Brar P., Kwon G.Y., Egbuna I.I., et al. Lack of correlation of degree of villous atrophy with severity of clinical presentation of coeliac disease. Dig Liver Dis 2007, 39:26-29.
25. Corazza G.R., Villanacci V., Zambelli C., et al. Comparison of the interobserver reproducibility with different histologic criteria used in celiac disease. Clin Gastroenterol Hepatol 2007, 5:838-843.
26. Valdimarsson T., Toss G., Ross I., et al. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994, 29:457-461.
27. Stenson W.F., Newberry R., Lorenz R., et al. Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med 2005, 165:393-399.
28. Virta L.J., Kaukinen K., Collin P. Incidence and prevalence of diagnosed coeliac disease in Finland: results of effective case finding in adults. Scand J Gastroenterol 2009, 44:933-938.
29. Ukkola A., Mäki M., Kurppa K., et al. Changes in body mass index on a gluten-free diet in coeliac disease: a nationwide study. Eur J Intern Med 2012, 23:384-388.
30. Riches P.L., McRorie E., Fraser W.D., et al. Osteoporosis associated with neutralizing autoantibodies against osteoprotegerin. N Engl J Med 2009, 361:1459-1465.
31. Moreno M.L., Crusius J.B., Cherñavsky A., et al. The IL-1 gene family and bone involvement in celiac disease. Immunogenetics 2005, 57:618-620.
32. Kakar S., Nehra V., Murray J.A., et al. Significance of intraepithelial lymphocytosis in small bowel biopsy samples with normal mucosal architecture. Am J Gastroenterol 2003, 98:2027-2033.
33. Rubio-Tapia A., Rahim M.W., See J.A., et al. Mucosal recovery and mortality in adults with celiac disease after treatment with a gluten-free diet. Am J Gastroenterol 2010, 105:1412-1420.
34. Vivas S., Ruiz de Morales J.M., Fernandez M., et al. Age-related clinical, serological, and histopathological features of celiac disease. Am J Gastroenterol 2008, 103:2360-2365.
35. Salmi T.T., Collin P., Korponay-Szabó I.R., et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006, 55:1746-1753.
36. West J., Logan R.F., Hill P.G., et al. The iceberg of celiac disease: what is below the waterline?. Clin Gastroenterol Hepatol 2007, 5:59-62.
37. Hill P.G., Holmes G.K. Coeliac disease: a biopsy is not always necessary for diagnosis. Aliment Pharmacol Ther 2008, 27:572-577.
38. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes 2006, 4:79. US Department of Health and Human Services FDA Center for Drug Evaluation and Research; US Department of Health and Human Services FDA Center for Biologics Evaluation and Research; US Department of Health and Human Services FDA Center for Devices and Radiological Health.
39. Shields A., Gwaltney C., Paty J., et al. Distinguishing among symptom vs. health related quality of life PRO concepts: developing a conceptual framework PRO Consulting white paper, Accessed April 7, 2012. http://www.patientreported.com.
40. Emery M.P., Perrier L.L., Acquadro C. Patient-reported outcome and quality of life instruments database (PROQOLID): frequently asked questions. Health Qual Life Outcomes 2005, 3:12.
41. Dorn S.D., Hernandez L., Minaya M.T., et al. The development and validation of a new coeliac disease quality of life survey (CD-QOL). Aliment Pharmacol Ther 2010, 31:666-675.
42. Häuser W., Gold J., Stallmach A., et al. Development and validation of the Celiac Disease Questionnaire (CDQ), a disease-specific health-related quality of life measure for adult patients with celiac disease. J Clin Gastroenterol 2007, 41:157-166.
43. Kurppa K., Collin P., Mäki M., et al. Celiac disease and health-related quality of life. Expert Rev Gastroenterol Hepatol 2011, 5:83-90.
44. Murray J.A., Rubio-Tapia A., Van Dyke C.T., et al. Mucosal atrophy in celiac disease: extent of involvement, correlation with clinical presentation, and response to treatment. Clin Gastroenterol Hepatol 2008, 6:186-193.